Correction: RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors.

Loi, Sherene; Dushyanthen, Sathana; Beavis, Paul A; Salgado, Roberto; Denkert, Carsten; Savas, Peter; Combs, Susan; Rimm, David L; Giltnane, Jennifer M; Estrada, Monica V; Sánchez, Violeta; Sanders, Melinda E; Cook, Rebecca S; Pilkinton, Mark A; Mallal, Simon A; Wang, Kai; Miller, Vincent A; Stephens, Phil J; Yelensky, Roman; Doimi, Franco D; Gómez, Henry; Ryzhov, Sergey V; Darcy, Phillip K; Arteaga, Carlos L; Balko, Justin M

Loi, Sherene; Dushyanthen, Sathana; Beavis, Paul A; Salgado, Roberto; Denkert, Carsten; Savas, Peter; Combs, Susan; Rimm, David L; Giltnane, Jennifer M; Estrada, Monica V; Sánchez, Violeta; Sanders, Melinda E; Cook, Rebecca S; Pilkinton, Mark A; Mallal, Simon A; Wang, Kai; Miller, Vincent A; Stephens, Phil J; Yelensky, Roman; Doimi, Franco D; Gómez, Henry; Ryzhov, Sergey V; Darcy, Phillip K; Arteaga, Carlos L; Balko, Justin M.

Clin Cancer Res ; 25(4): 1437, 2019 Feb 15.

Article em En | MEDLINE | ID: mdl-30770496

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Clin Cancer Res Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google